William P. Sheridan
2015
In 2015, William P. Sheridan earned a total compensation of $1.6M as Senior Vice President and Chief Medical Officer at BioCryst Pharmaceuticals, a 34% decrease compared to previous year.
Compensation breakdown
| Option Awards | $941,072 |
|---|---|
| Salary | $444,369 |
| Stock Awards | $132,554 |
| Other | $50,585 |
| Total | $1,568,570 |
Sheridan received $941.1K in option awards, accounting for 60% of the total pay in 2015.
Sheridan also received $444.4K in salary, $132.6K in stock awards and $50.6K in other compensation.
Rankings
In 2015, William P. Sheridan's compensation ranked 5,766th out of 13,638 executives tracked by ExecPay. In other words, Sheridan earned more than 57.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,766 out of 13,638 | 58th |
Division Manufacturing | 2,150 out of 5,190 | 59th |
Major group Chemicals And Allied Products | 773 out of 1,854 | 58th |
Industry group Drugs | 614 out of 1,528 | 60th |
Industry Biological Products, Except Diagnostic Substances | 105 out of 254 | 59th |
Source: SEC filing on April 11, 2016.
Sheridan's colleagues
We found four more compensation records of executives who worked with William P. Sheridan at BioCryst Pharmaceuticals in 2015.
2015
Lynne Powell
BioCryst Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2015
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2015
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2015
Yarlagadda Babu
BioCryst Pharmaceuticals